Carrie L. Anderson's most recent trade in Campbell Soup Co. was a trade of 3,671 Common Stock done at an average price of $39.8 . Disclosure was reported to the exchange on March 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Campbell Soup Co. | Carrie L. Anderson | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.85 per share. | 01 Mar 2025 | 3,671 | 68,866 (0%) | 0% | 39.8 | 146,289 | Common Stock |
| Embecta Corp | Carrie L. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2025 | 13,839 | 39,743 | - | 0 | Common Stock | |
| Campbell Soup Co. | Carrie L. Anderson | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 17,802 | 72,537 (0%) | 0% | 0 | Common Stock | |
| Campbell Soup Co. | Carrie L. Anderson | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 49.36 per share. | 30 Sep 2024 | 2,072 | 54,735 (0%) | 0% | 49.4 | 102,274 | Common Stock |
| Campbell Soup Co. | Carrie L. Anderson | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 42.64 per share. | 01 Mar 2024 | 3,664 | 56,807 (0%) | 0% | 42.6 | 156,233 | Common Stock |
| Embecta Corp | Anderson Carrie L. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2024 | 11,455 | 24,897 | - | 0 | Common Stock | |
| Campbell Soup Co. | Carrie L. Anderson | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2023 | 21,868 | 60,471 (0%) | 0% | 0 | Common Stock | |
| Campbell Soup Co. | Carrie L. Anderson | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 21,868 | 60,471 (0%) | 0% | 0 | Common Stock | |
| Campbell Soup Co. | Carrie L. Anderson | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 38,603 | 38,603 (0%) | 0% | 0 | Common Stock | |
| Embecta Corp | Carrie L. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 6,979 | 13,068 | - | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Carrie L. Anderson | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.00 per share. | 01 Jul 2022 | 4,425 | 57,811 (0%) | 0% | 55 | 243,375 | Common Stock |
| Embecta Corp | Carrie L. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2022 | 6,024 | 6,024 | - | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Carrie L. Anderson | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 17,539 | 17,539 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Carrie L. Anderson | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 11,519 | 68,217 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Carrie L. Anderson | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2022 | 6,236 | 56,698 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Carrie L. Anderson | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 2,296 | 62,236 (0%) | 0% | 65.1 | 149,493 | Common Stock |
| Integra Lifesciences Holdi... | Carrie L. Anderson | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 1,744 | 66,037 (0%) | 0% | 65.1 | 113,552 | Common Stock |
| Integra Lifesciences Holdi... | Carrie L. Anderson | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 807 | 64,532 (0%) | 0% | 65.1 | 52,544 | Common Stock |
| Integra Lifesciences Holdi... | Carrie L. Anderson | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 698 | 65,339 (0%) | 0% | 65.1 | 45,447 | Common Stock |
| Integra Lifesciences Holdi... | Carrie L. Anderson | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 65.11 per share. | 11 Mar 2022 | 436 | 67,781 (0%) | 0% | 65.1 | 28,388 | Common Stock |
| Integra Lifesciences Holdi... | Carrie L. Anderson | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 8,904 | 50,462 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Carrie L. Anderson | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 7,131 | 41,558 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Carrie L. Anderson | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 69.13 per share. | 01 Jul 2021 | 3,531 | 34,427 (0%) | 0% | 69.1 | 244,098 | Common Stock |
| Integra Lifesciences Holdi... | Carrie L. Anderson | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 14,526 | 14,526 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdi... | Carrie L. Anderson | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 4,819 | 38,480 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdi... | Carrie L. Anderson | Executive Vice President & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 522 | 37,958 (0%) | 0% | 68.1 | 35,548 | Common Stock |